1Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/ JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence- based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011, 183:788-824. 被引量：1
3Nagai S, Kitaichi M, Hamada K, et al. Hospital-based historical cohort study of 234 histologically proven Japanese patients with IPF. Sarcnidosis Vasc Diffuse Lung Dis, 1999, 16:209-214. 被引量：1
4Raghu G, Depaso WJ,' Cain K, et al. Azathioprine combined with prednisone in the treatment of idiopathic pulmonary fibrosis: a prospective double-blind, randomized, placebo-controlled clinical trial. Am Rev Respir Dis, 1991, 144:291-296. 被引量：1
5Johnson MA, Kwan S, Snell NJ, et al. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax, 1989, 44:280-288. 被引量：1
6Selman M, Carrillo G, Salas J, et al. Colchicine, D- penicillamine, and prednisone in the treatment of idiopathic pulmonary fibrosis : a controlled clinical trial. Chest, 1998, 114 : 507-512. 被引量：1
7Douglas WW, Ryu JH, Swensen SJ, et al. Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis: a randomized prospective study. Am J Respir Crit Care Med, 1998, 158:220-225. 被引量：1
8Noble PW, Albera C, Bradford WZ, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY) : two randomised trials. Lancet, 2011, 377 : 1760-1769. 被引量：1
9Azuma A, Nukiwa T, Tsuboi E, et al. Double-blind, placebo- controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2005, 171:1040-1047. 被引量：1
10Taniguchi H, Ebina M, Kondoh Y, et al. Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J, 2010, 35:821-829. 被引量：1
